Part 1 - Examining the Implications of Clinical Pathways on the Oncology Marketplace

Part 1 - Examining the Implications of Clinical Pathways on the Oncology Marketplace

In this episode, we start a two-part discussion with Ron Schleif, co-founder and Principle of Oncology Reimbursement Management, a consulting and research services firm that helps life sciences companies determine whether their oncology products are positioned for maximum success. We ask Ron about the increasing use of oncology clinical pathways by payers and providers. Ron shares insights from a presentation he made at last year's  CONFERA conference  entitled, “Examining the Implications of Clinical Pathways on the Oncology Marketplace." The focus of today's conversation is on clinical treatment pathways and the different models being used to reduce variation in care, enhance quality of care, and maximize clinical and economic outcomes.
Ron Schleif can be reached at [email protected]